Home >> Research Area >> MRS 4062 triethylammonium salt

MRS 4062 triethylammonium salt

Selective P2Y4 receptor agonist CAS# 1309871-50-8

MRS 4062 triethylammonium salt

2D Structure

Catalog No. BCC6134----Order now to get a substantial discount!

Product Name & Size Price Stock
MRS 4062 triethylammonium salt: 5mg $1599 In Stock
MRS 4062 triethylammonium salt: 10mg Please Inquire In Stock
MRS 4062 triethylammonium salt: 20mg Please Inquire Please Inquire
MRS 4062 triethylammonium salt: 50mg Please Inquire Please Inquire
MRS 4062 triethylammonium salt: 100mg Please Inquire Please Inquire
MRS 4062 triethylammonium salt: 200mg Please Inquire Please Inquire
MRS 4062 triethylammonium salt: 500mg Please Inquire Please Inquire
MRS 4062 triethylammonium salt: 1000mg Please Inquire Please Inquire
Related Products

Quality Control of MRS 4062 triethylammonium salt

3D structure

Package In Stock

MRS 4062 triethylammonium salt

Number of papers citing our products

Chemical Properties of MRS 4062 triethylammonium salt

Cas No. 1309871-50-8 SDF Download SDF
PubChem ID 90488925 Appearance Powder
Formula C42H86N7O15P3 M.Wt 1022.09
Type of Compound N/A Storage Desiccate at -20°C
Solubility Soluble in water (supplied pre-dissolved at a concentration of 10mM)
Chemical Name [[[(2R,3S,4R,5R)-3,4-dihydroxy-5-[2-oxo-4-(3-phenylpropoxyamino)pyrimidin-1-yl]oxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] phosphate;triethylazanium
SMILES CC[NH+](CC)CC.CC[NH+](CC)CC.CC[NH+](CC)CC.CC[NH+](CC)CC.C1=CC=C(C=C1)CCCONC2=NC(=O)N(C=C2)C3C(C(C(O3)COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])O)O
Standard InChIKey ZCDZFMKRHPANNI-IHQKQWLFSA-N
Standard InChI InChI=1S/C18H26N3O15P3.4C6H15N/c22-15-13(11-33-38(28,29)36-39(30,31)35-37(25,26)27)34-17(16(15)23)21-9-8-14(19-18(21)24)20-32-10-4-7-12-5-2-1-3-6-12;4*1-4-7(5-2)6-3/h1-3,5-6,8-9,13,15-17,22-23H,4,7,10-11H2,(H,28,29)(H,30,31)(H,19,20,24)(H2,25,26,27);4*4-6H2,1-3H3/t13-,15-,16-,17-;;;;/m1..../s1
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Biological Activity of MRS 4062 triethylammonium salt

DescriptionSelective P2Y4 receptor agonist (EC50 values are 23, 640, and 740 nM for hP2Y4, hP2Y2 and hP2Y6 respectively).

MRS 4062 triethylammonium salt Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

MRS 4062 triethylammonium salt Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of MRS 4062 triethylammonium salt

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 0.9784 mL 4.8919 mL 9.7839 mL 19.5677 mL 24.4597 mL
5 mM 0.1957 mL 0.9784 mL 1.9568 mL 3.9135 mL 4.8919 mL
10 mM 0.0978 mL 0.4892 mL 0.9784 mL 1.9568 mL 2.446 mL
50 mM 0.0196 mL 0.0978 mL 0.1957 mL 0.3914 mL 0.4892 mL
100 mM 0.0098 mL 0.0489 mL 0.0978 mL 0.1957 mL 0.2446 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University
Featured Products
New Products
 

References on MRS 4062 triethylammonium salt

Pyrimidine nucleotides with 4-alkyloxyimino and terminal tetraphosphate delta-ester modifications as selective agonists of the P2Y(4) receptor.[Pubmed:21528910]

J Med Chem. 2011 Jun 23;54(12):4018-33.

P2Y(2) and P2Y(4) receptors are G protein-coupled receptors, activated by UTP and dinucleoside tetraphosphates, which are difficult to distinguish pharmacologically for lack of potent and selective ligands. We structurally varied phosphate and uracil moieties in analogues of pyrimidine nucleoside 5'-triphosphates and 5'-tetraphosphate esters. P2Y(4) receptor potency in phospholipase C stimulation in transfected 1321N1 human astrocytoma cells was enhanced in N(4)-alkyloxycytidine derivatives. OH groups on a terminal delta-glucose phosphoester of uridine 5'-tetraphosphate were inverted or substituted with H or F to probe H-bonding effects. N(4)-(Phenylpropoxy)-CTP 16 (MRS4062), Up(4)-[1]3'-deoxy-3'-fluoroglucose 34 (MRS2927), and N(4)-(phenylethoxy)-CTP 15 exhibit >/=10-fold selectivity for human P2Y(4) over P2Y(2) and P2Y(6) receptors (EC(50) values 23, 62, and 73 nM, respectively). delta-3-Chlorophenyl phosphoester 21 of Up(4) activated P2Y(2) but not P2Y(4) receptor. Selected nucleotides tested for chemical and enzymatic stability were much more stable than UTP. Agonist docking at CXCR4-based P2Y(2) and P2Y(4) receptor models indicated greater steric tolerance of N(4)-phenylpropoxy group at P2Y(4). Thus, distal structural changes modulate potency, selectivity, and stability of extended uridine tetraphosphate derivatives, and we report the first P2Y(4) receptor-selective agonists.

Keywords:

MRS 4062 triethylammonium salt,1309871-50-8,Natural Products, buy MRS 4062 triethylammonium salt , MRS 4062 triethylammonium salt supplier , purchase MRS 4062 triethylammonium salt , MRS 4062 triethylammonium salt cost , MRS 4062 triethylammonium salt manufacturer , order MRS 4062 triethylammonium salt , high purity MRS 4062 triethylammonium salt

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: